Novartis AG
NVSEFOTCHealthcare● Active
$148.80
+$4.66(+3.23%)
Market Cap$283.9B
P/E Ratio—
52W High$171.29
52W Low$110.74
Novartis AG (NVSEF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NVSEF · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $57.13B | $51.72B | $46.66B | $51.83B | $52.88B |
| Cost of Revenue | $14.27B | $12.83B | $12.02B | $15.49B | $15.87B |
| Gross Profit | $42.86B | $38.90B | $34.64B | $36.34B | $37.01B |
| Gross Margin %(computed) | 75.02% | 75.20% | 74.24% | 70.12% | 69.99% |
| Operating Expenses | |||||
| R&D Expenses | $11.20B | $10.02B | $11.37B | $10.00B | $9.54B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $25.06B | $24.35B | $24.87B | $27.14B | $25.32B |
| Operating Income | $17.80B | $14.54B | $9.77B | $9.20B | $11.69B |
| Operating Margin %(computed) | 31.15% | 28.12% | 20.94% | 17.75% | 22.11% |
| Interest Income | $0.39B | $0.55B | $0.44B | $0.39B | $0.07B |
| Interest Expense | $1.24B | $1.01B | $0.85B | $0.86B | $0.91B |
| Income Before Tax | $17.13B | $13.64B | $9.12B | $8.37B | $25.02B |
| Income Tax Expense | $2.50B | $1.70B | $0.55B | $1.42B | $2.12B |
| Net Income | $14.65B | $11.94B | $14.85B | $6.96B | $24.02B |
| Net Margin %(computed) | 25.64% | 23.09% | 31.83% | 13.42% | 45.43% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $7.56 | $5.92 | $7.63 | $3.29 | $10.73 |
| Wtd Avg Shares | 1.94B | 2.02B | 2.08B | 2.18B | 2.24B |
| EBITDA | $23.96B | $20.71B | $19.52B | $15.21B | $17.17B |
| EBITDA Margin %(computed) | 41.94% | 40.05% | 41.83% | 29.35% | 32.47% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Novartis AG data
About Novartis AG (NVSEF) Income Statement
Novartis AG (NVSEF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, NVSEF reported revenue of $57.13B, gross profit of $42.86B (gross margin 75.02%), and net income of $14.65B — a net profit margin of 25.64%.
Frequently asked questions
NVSEF · 4 questionsNovartis AG (NVSEF) reported revenue of $57.13B for 2025, up 10.4% year-over-year.
NVSEF revenueNVSEF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08